ARTICLE | Company News
Jubilant Life Sciences, Checkpoint Therapeutics deal
June 6, 2016 7:00 AM UTC
Jubilant’s Jubilant Biosys Ltd. subsidiary granted Checkpoint exclusive, worldwide rights to patents covering compounds that inhibit bromodomain containing 4 (BRD4) to treat cancer. Jubilant Biosys wi...